Access to anti-retroviral drugs, male in Oman
Oman: Access to anti-retroviral drugs, male was 65.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, male in Oman, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Oman stood at 65.0%. That is the highest value across all 25 years on record.
The figure is up 4.8% on the previous year and up 109.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Oman peaked at 65.0% in 2024 and was at its lowest, 15.0%, in 2000.
Oman ranks 83rd of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, male in Oman, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 15.0% | — |
| 2001 | 16.0% | +6.7% |
| 2002 | 17.0% | +6.2% |
| 2003 | 17.0% | +0.0% |
| 2004 | 18.0% | +5.9% |
| 2005 | 18.0% | +0.0% |
| 2006 | 19.0% | +5.6% |
| 2007 | 20.0% | +5.3% |
| 2008 | 26.0% | +30.0% |
| 2009 | 31.0% | +19.2% |
| 2010 | 34.0% | +9.7% |
| 2011 | 29.0% | -14.7% |
| 2012 | 27.0% | -6.9% |
| 2013 | 30.0% | +11.1% |
| 2014 | 31.0% | +3.3% |
| 2015 | 29.0% | -6.5% |
| 2016 | 31.0% | +6.9% |
| 2017 | 35.0% | +12.9% |
| 2018 | 40.0% | +14.3% |
| 2019 | 48.0% | +20.0% |
| 2020 | 51.0% | +6.2% |
| 2021 | 57.0% | +11.8% |
| 2022 | 57.0% | +0.0% |
| 2023 | 62.0% | +8.8% |
| 2024 | 65.0% | +4.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.7% | 15.0% | 31.0% | 10 |
| 2010s | 33.4% | 27.0% | 48.0% | 10 |
| 2020s | 58.4% | 51.0% | 65.0% | 5 |
Countries ranked near Oman
More gender data for Oman
- Child population (UN estimates and projections) 1,409 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1678 % change on previous year (2030)
- Population 4,704 (2030)
- Working-age population (UN estimates and projections) 4,704 (2030)
- Population (UN estimates and projections), annual growth rate 1.82 % change on previous year (2030)
- Age population, age 00, female, interpolated 43,819 (2025)
- Age population, age 00, male, interpolated 45,624 (2025)
- Age population, age 01, female, interpolated 41,956 (2025)
- Age population, age 01, male, interpolated 43,673 (2025)
- Age population, age 02, female, interpolated 39,215 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Oman?
- Access to anti-retroviral drugs, male in Oman was 65.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Oman?
- The highest recorded value was 65.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Oman?
- The lowest recorded value was 15.0% in 2000.
- How does Oman rank for access to anti-retroviral drugs, male?
- Oman ranks 83rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Oman?
- Over the last ten years it is up 109.7%. The long-run trend across the full record is rising.
- Where does this Oman data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.